{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:21:32Z","timestamp":1790680892032,"version":"4.1.0"},"reference-count":24,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1001\/jamadermatol.2018.5453","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:23:46Z","timestamp":1551266626000},"page":"442","source":"Crossref","is-referenced-by-count":40,"title":["Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy"],"prefix":"10.1001","volume":"155","author":[{"given":"Lillian","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Re-I","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Gastman","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wade","family":"Thorstad","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue S.","family":"Yom","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana A.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Nussenbaum","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, University of Arizona, Tucson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Knackstedt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison T.","family":"Vidimos","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo A.","family":"Koyfman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu V.","family":"Manyam","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"doi180084r1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/TP.0b013e3181ec7228","article-title":"Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients.","volume":"90","author":"Lott","year":"2010","journal-title":"Transplantation"},{"issue":"7","key":"doi180084r2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/archderm.140.7.837","article-title":"Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island Follow-Back Study.","volume":"140","author":"Lewis","year":"2004","journal-title":"Arch Dermatol"},{"issue":"12","key":"doi180084r3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/ijd.2011.50.issue-12","article-title":"Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.","volume":"50","author":"Zavos","year":"2011","journal-title":"Int J Dermatol"},{"issue":"8","key":"doi180084r4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"issue":"2","key":"doi180084r5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/hed.v38.2","article-title":"ACR Appropriateness Criteria aggressive nonmelanomatous skin cancer of the head and neck.","volume":"38","author":"Koyfman","year":"2016","journal-title":"Head Neck"},{"issue":"11","key":"doi180084r6","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/hed.v34.11","article-title":"Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy.","volume":"34","author":"Wang","year":"2012","journal-title":"Head Neck"},{"issue":"1, pt 1","key":"doi180084r7","doi-asserted-by":"publisher","first-page":"C251","DOI":"10.1152\/ajpcell.1998.275.1.C251","article-title":"Physiological effects of Na+\/Ca2+ exchanger knockdown by antisense oligodeoxynucleotides in arterial myocytes.","volume":"275","author":"Slodzinski","year":"1998","journal-title":"Am J Physiol"},{"issue":"2","key":"doi180084r9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jaad.2015.04.037","article-title":"Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.","volume":"73","author":"Manyam","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"doi180084r10","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/cncr.v123.11","article-title":"A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.","volume":"123","author":"Manyam","year":"2017","journal-title":"Cancer"},{"issue":"10","key":"doi180084r11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/(ISSN)1097-0347","article-title":"Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).","volume":"27","author":"Bernier","year":"2005","journal-title":"Head Neck"},{"issue":"13","key":"doi180084r12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2017.77.0941","article-title":"Postoperative concurrent chemoradiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: the randomized phase III TROG 05.01 trial.","volume":"36","author":"Porceddu","year":"2018","journal-title":"J Clin Oncol"},{"issue":"25","key":"doi180084r13","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1200\/JCO.2010.34.1735","article-title":"Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin.","volume":"29","author":"Maubec","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"doi180084r14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1200\/JCO.2002.20.2.364","article-title":"Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer.","volume":"20","author":"Shin","year":"2002","journal-title":"J Clin Oncol"},{"issue":"8","key":"doi180084r15","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin.","volume":"66","author":"Sadek","year":"1990","journal-title":"Cancer"},{"issue":"6","key":"doi180084r16","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jaad.2017.07.048","article-title":"Gefitinib for patients with incurable cutaneous squamous cell carcinoma: a single-arm phase II clinical trial.","volume":"77","author":"William","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"26","key":"doi180084r17","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma.","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"doi180084r18","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma.","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"issue":"26","key":"doi180084r19","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma.","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"},{"issue":"19","key":"doi180084r20","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma.","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"issue":"18","key":"doi180084r21","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway.","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N Engl J Med"},{"issue":"20","key":"doi180084r22","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1056\/NEJMc1508163","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma.","volume":"373","author":"Chan","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"doi180084r23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma.","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"doi180084r24","first-page":"CD004424","article-title":"Antiepileptic drugs for preventing seizures in people with brain tumors.","author":"Tremont-Lukats","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"doi180084r8","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: squamous cell skin cancer. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/squamous.pdf. Accessed January 22, 2019."}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamadermatology\/article-pdf\/155\/4\/442\/17478258\/jamadermatology_sun_2019_oi_180084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T11:05:10Z","timestamp":1554894310000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.5453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.5453","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735170830.793559695","asserted-by":"object"}]},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}